EAGLE, Idaho, March 20, 2023 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice, home care and senior living companies, today announced that it has completed the acquisition of operations of Robins Landing at New Berlin, a 44-bed memory care and assisted living facility located in New Berlin, Wisconsin, and Robins Landing at Brookfield, a 52-bed memory care and assisted living facility located in Brookfield, Wisconsin. The acquisition was effective March 16, 2023 and will be subject to a long-term, triple-net lease.
“We are very excited to expand our senior living offerings in the State of Wisconsin,” said Brent Guerisoli, Chief Executive Officer of Pennant. “This acquisition complements our existing operations in the area, including home health, hospice, and a strong network of senior living communities,” Guerisoli added.
“We could not be happier to add Robins Landing at New Berlin, and Robins Landing at Brookfield. Our Wisconsin leaders are eager and excited by the opportunity to turn these operations into the employers of choice and communities of choice in New Berlin and Brookfield,” added Andrew Rider, President of Pinnacle Senior Living LLC, Pennant’s senior living subsidiary.
Mr. Guerisoli reaffirmed that Pennant continues to pursue opportunities to acquire high quality home health, hospice, home care and senior living businesses throughout the United States.
About Pennant:
The Pennant Group, Inc. is a holding company of independent operating subsidiaries that provide healthcare services through 95 home health and hospice agencies and 51 senior living communities located throughout Arizona, California, Colorado, Idaho, Iowa, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin and Wyoming. Each of these businesses is operated by a separate, independent operating subsidiary that has its own management, employees and assets. References herein to the consolidated "company" and "its" assets and activities, as well as the use of the terms "we," "us," "its" and similar verbiage, are not meant to imply that The Pennant Group, Inc. has direct operating assets, employees or revenue, or that any of the home health and hospice businesses, senior living communities or the Service Center are operated by the same entity. More information about Pennant is available at www.pennantgroup.com.
Contact Information
The Pennant Group, Inc.
(208) 506-6100
This email address is being protected from spambots. You need JavaScript enabled to view it.
Last Trade: | US$31.71 |
Daily Change: | 1.15 3.76 |
Daily Volume: | 456,014 |
Market Cap: | US$957.960M |
November 06, 2024 November 01, 2024 September 30, 2024 August 06, 2024 August 01, 2024 |
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MORERecursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB